"10.1371_journal.pone.0070378","plos one","2013-07-25T00:00:00Z","Rebecca Kuepper; Jenny Ceccarini; Johan Lataster; Jim van Os; Marinus van Kroonenburgh; Joop M A van Gerven; Machteld Marcelis; Koen Van Laere; CÃ©cile Henquet","Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, Maastricht, The Netherlands; PsyQ Heerlen, Mondriaan, South Limburg, The Netherlands; Division of Nuclear Medicine, University Hospital and Catholic University, Leuven, Belgium; Faculty of Psychology, Open University of the Netherlands, Heerlen, The Netherlands; Department of Psychosis Studies, Institute of Psychiatry, Kings Health Partners, Kings College London, London, United Kingdom; Division of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands; Centre for Human Drug Research, Leiden, The Netherlands","Conceived and designed the experiments: RK JC MvK KVL CH JvG JvO. Performed the experiments: RK CH MM. Analyzed the data: RK JC JL. Contributed reagents/materials/analysis tools: KvL JvL MvK JvO. Wrote the paper: RK CJ JL CH JvO.","J. van Os is/has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. All other authors declare no conflict of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Rebecca Kuepper","RK",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
